|
|
Post by anderson on Apr 14, 2020 12:12:38 GMT -5
So does making biosimilars easier to get through the FDA give us hope that we can finally use that pfizer insulin stockpile? The Amphastar agreement goes out to 2026. So not taking into account the current cash situation, should Mannkind have a plan to get the pfizer insulin approved and then create a production plant so they can vertically integrate? ( and yes they already bought the rights to manufacture for the purpose of making Afreezza)
|
|
|
|
Post by rfogel on Apr 14, 2020 12:41:51 GMT -5
Are you sure a Pfizer insulin stockpile exists? I have seen it mentioned elsewhere but I can't find any mention of it in the SEC filings.
|
|
|
|
Post by itellthefuture777 on Apr 14, 2020 12:59:44 GMT -5
So does making biosimilars easier to get through the FDA give us hope that we can finally use that pfizer insulin stockpile? The Amphastar agreement goes out to 2026. So not taking into account the current cash situation, should Mannkind have a plan to get the pfizer insulin approved and then create a production plant so they can vertically integrate? ( and yes they already bought the rights to manufacture for the purpose of making Afreezza)
You mean the $10 billion sales worth of Insulin Mannkind bought for only $3 million bucks from Pfizer? Pfizer that only wanted all Mannkind stock for that German factory that Sanofi swooped in and bought before getting in a $1 billion deal with Mannkind...that insulin? |
|
|
|
Post by brentie on Apr 14, 2020 13:13:49 GMT -5
Are you sure a Pfizer insulin stockpile exists? I have seen it mentioned elsewhere but I can't find any mention of it in the SEC filings. This is from 4 years ago.... Can the insulin from Pfizer be used and is it cleared by the FDA? It has been stated to be sufficient to manufacture $10B of product. Just prior to the agreement with Sanofi, MannKind completed CMC studies and a clinical bioequivalence study leading to a potential submission of the HMR 4006 insulin acquired from Pfizer. Based on the current age of the HMR 4006 inventories, MannKind is evaluating various options and utility for future use. There is currently sufficient inventory of Amphastar insulin for near term needs. www.mannkindcorp.com/Collateral/Documents/English-US/MNKD%202%203%2016%20Investor%20Call%20FAQ%20v2%209%2016%20FINAL.pdf |
|
|
|
Post by peppy on Apr 14, 2020 13:34:19 GMT -5
Are you sure a Pfizer insulin stockpile exists? I have seen it mentioned elsewhere but I can't find any mention of it in the SEC filings. This is from 4 years ago.... Can the insulin from Pfizer be used and is it cleared by the FDA? It has been stated to be sufficient to manufacture $10B of product. Just prior to the agreement with Sanofi, MannKind completed CMC studies and a clinical bioequivalence study leading to a potential submission of the HMR 4006 insulin acquired from Pfizer. Based on the current age of the HMR 4006 inventories, MannKind is evaluating various options and utility for future use. There is currently sufficient inventory of Amphastar insulin for near term needs. www.mannkindcorp.com/Collateral/Documents/English-US/MNKD%202%203%2016%20Investor%20Call%20FAQ%20v2%209%2016%20FINAL.pdfBrent, you remember, the amphaster insulin verified for lack of the correct word for afrezza, the Pfizer insulin needs to meet the same regulation. Something like that? A pay to play. |
|
|
|
Post by itellthefuture777 on Apr 14, 2020 13:46:07 GMT -5
Are you sure a Pfizer insulin stockpile exists? I have seen it mentioned elsewhere but I can't find any mention of it in the SEC filings. This is from 4 years ago.... Can the insulin from Pfizer be used and is it cleared by the FDA? It has been stated to be sufficient to manufacture $10B of product. Just prior to the agreement with Sanofi, MannKind completed CMC studies and a clinical bioequivalence study leading to a potential submission of the HMR 4006 insulin acquired from Pfizer. Based on the current age of the HMR 4006 inventories, MannKind is evaluating various options and utility for future use. There is currently sufficient inventory of Amphastar insulin for near term needs. www.mannkindcorp.com/Collateral/Documents/English-US/MNKD%202%203%2016%20Investor%20Call%20FAQ%20v2%209%2016%20FINAL.pdf I think Mat in a call mentioned back then because of that they didn't put it on the books so to speak..but now...hmm $10 billion sales worth..of insulin..already paid for and owned for only $3 million..hmmmmmm interesting |
|
|
|
Post by itellthefuture777 on Apr 14, 2020 13:52:57 GMT -5
"VALENCIA, Calif.--(BUSINESS WIRE)--Jun. 22, 2009-- MannKind Corporation (Nasdaq:MNKD) today announced that it has completed its acquisition from Pfizer Inc. (NYSE:PFE) of a quantity of bulk insulin and a license to manufacture bulk insulin for use in pulmonary delivery pursuant to an insulin sale and purchase agreement. Upon the closing, MannKind and Pfizer also entered into an agreement pursuant to which MannKind agreed to maintain and store the remainder of Pfizer’s bulk insulin inventory and acquired an option to purchase the remaining insulin, in whole or in part, at a specified price, to the extent that Pfizer has not otherwise disposed of or used the remaining insulin. The total purchase price for this transaction, including consideration payable to MannKind for its storage and maintenance obligations, was $3 million, which MannKind paid in cash." investors.mannkindcorp.com/news-releases/news-release-details/mannkind-closes-acquisition-insulin-assets-pfizer |
|
|
|
Post by cretin11 on Apr 14, 2020 18:11:52 GMT -5
So does making biosimilars easier to get through the FDA give us hope that we can finally use that pfizer insulin stockpile? The Amphastar agreement goes out to 2026. So not taking into account the current cash situation, should Mannkind have a plan to get the pfizer insulin approved and then create a production plant so they can vertically integrate? ( and yes they already bought the rights to manufacture for the purpose of making Afreezza)
You mean the $10 billion sales worth of Insulin Mannkind bought for only $3 million bucks from Pfizer? Pfizer that only wanted all Mannkind stock for that German factory that Sanofi swooped in and bought before getting in a $1 billion deal with Mannkind...that insulin? Yes, based on your exciting discovery, MNKD market cap should be in the neighborhood of $10 billion. Should happen quite soon. |
|
|
|
Post by mango on Apr 14, 2020 19:50:23 GMT -5
|
|
|
|
Post by mannmade on Apr 14, 2020 23:43:44 GMT -5
As I recall while they originally thought they might use this insulin for Afrezza, but after the amphastar deal, it was decided better to resell this insulin at some point, since no one was exactly clear on the shelf life. I beleive it was kept on the books but ultimately not to be used for Afrezza.
|
|
|
|
Post by sportsrancho on Apr 15, 2020 2:31:38 GMT -5
As I recall while they originally thought they might use this insulin for Afrezza, but after the amphastar deal, it was decided better to resell this insulin at some point, since no one was exactly clear on the shelf life. I beleive it was kept on the books but ultimately not to be used for Afrezza. Right |
|
|
|
Post by cretin11 on Apr 15, 2020 9:16:38 GMT -5
So it was all sold in 2017? If not, then it makes no sense why we haven’t been selling it continuously since then. Would rather have $$$ than a bunch of extra insulin that isn’t suitable for use in Afrezza.
|
|
/production/original_573352236.gif)
